Should a leadless pacemaker be implanted in the right ventricle (mid‑septal, low‑septal, or apical location)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Leadless Pacemaker Placement in the Right Ventricle

Leadless pacemakers should be implanted in the right ventricular mid-septum rather than the apex, as this location reduces the risk of cardiac perforation while maintaining excellent electrical performance. 1, 2

Optimal Implantation Site

The mid-septal location is the preferred target for leadless pacemaker deployment, with studies demonstrating successful mid-septal placement in 90-94% of cases when proper fluoroscopic guidance is used. 1, 2 This represents a significant departure from traditional transvenous lead placement, where the right ventricular apex has historically been the most common site. 3

Why Mid-Septum Over Apex

The primary advantage of mid-septal placement is substantially lower perforation risk, which is the major complication associated with apical leadless pacemaker implantation. 1 In high-risk cohorts—including patients over 80 years old, those with BMI <20 kg/m², renal dysfunction, and valvular heart disease—mid-septal implantation achieved a complication rate of only 2% for perforation. 1

Specific Anatomic Targets

For leadless pacemakers, the acceptable implantation zones within the right ventricle include:

  • Mid-septum (preferred): 90% of successful cases 1
  • Low-septum/apical septum: 10% of cases 1
  • Mid-to-apical right ventricular septum: Primary location in dual-chamber systems 4

The traditional right ventricular apex, while still used for conventional transvenous leads 5, 3, carries higher perforation risk for leadless devices due to the thinner myocardial wall at this location. 1

Fluoroscopic Guidance Technique

Three fluoroscopic views are essential for accurate mid-septal placement: right anterior oblique (RAO), left anterior oblique (LAO), and left lateral views. 1 The left lateral view is particularly critical, as 17.6% of devices that appeared septal on RAO and LAO views were actually directed toward the free wall when verified laterally. 1

Positioning Criteria by View

  • RAO view: Device positioned at the center of the cardiac silhouette 1
  • LAO view: Device directed toward the left 1
  • Left lateral view: Device positioned away from the sternum (anteriorly) 1

Right ventriculography significantly improves accuracy, increasing correct mid-septal placement from 48% to 94% while simultaneously reducing X-ray exposure time (7.79 vs. 12.03 minutes) and radiation dose (565 vs. 826 mGy). 2 This technique illustrates the RV septum directly and reduces the number of repositioning attempts from 6.4 to 2.8. 2

Electrical Performance

Mid-septal leadless pacemaker placement demonstrates excellent chronic electrical characteristics:

  • Pacing thresholds: Improve from 0.8±0.6V at implant to 0.6±0.4V at 1 month, then remain stable through 6 months 4
  • R-wave sensing: Mean 9.7±4.0 mV at implantation, improving to 11.7±4.2 mV at 1 month 1, 4
  • Impedance: Stable throughout follow-up 1, 4

Importantly, electrical metrics do not differ significantly among various septal implant locations (mid vs. apical septum), indicating that any septal position provides reliable performance. 4

Common Pitfalls to Avoid

Never rely solely on RAO and LAO views—the left lateral view is mandatory to exclude free wall positioning that mimics septal location on standard oblique projections. 1 One perforation in the reported series occurred specifically because contrast was injected against the RV anterior wall before lateral view verification. 1

Avoid the coronary sinus, which can be mistaken for the right ventricle; leads in the coronary sinus direct posteriorly on lateral view, while true RV leads project anteriorly. 5

Clinical Context

Leadless pacemakers are indicated for single-chamber ventricular pacing only (VVI mode), appropriate for patients with permanent atrial fibrillation, symptomatic bradyarrhythmias where atrial contribution is not needed, or following AV junction ablation. 3, 6 These devices eliminate lead-related complications (fracture, extraction challenges) and pocket complications (infection, disfigurement) that affect 2.2-4.3% of conventional transvenous leads. 5, 6

For dual-chamber leadless systems, the ventricular component is similarly placed at the mid-to-apical RV septum, with the atrial component in the right atrial appendage anterior base. 4

References

Research

Right ventriculography improves the accuracy of leadless pacemaker implantation in right ventricular mid-septum.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2023

Guideline

Single Chamber Pacemaker Lead Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.